The Deal
Saturday, November 21, 
9:50 pm

— Takeda —

Top tags

You have executed a tag search on The Deal Newsweekly. To the right you will find a comprehensive list of stories tagged "Takeda." Below are the most-popular tags for The Deal Newsweekly. On the right of the page you will find a search box to dig deeper into our content.

Community

Editor's Note

Editor's letter: Nov. 16, 2009

By Robert Teitelman

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.


Regulatory

Of politics and pay

By Arthur F. Woodard

How to fix executive compensation rules without breaking the companies.


Industry Insight

Before the honeymoon ends

By Frank Aquila and Kathy Byran

Thinking differently about conflict resolution.


Judgment Call

The price of R&D

By Terri Garland and Mark Maxson

FAS 141(R): A new source of shareholder litigation against innovation-driven companies?


•  Community Home
•  The Deal On Facebook

Entries tagged "Takeda"

ImClone

Massachusetts' State-Boston Pension Fund has stepped in with a lawsuit to block Eli Lilly's $6.5 billion deal for ImClone.


Takeda

Takeda made a big splash in the Spring with its $8.8B deal for Millennium. But does it have more deals in the pipeline?


The Japanese are coming

Japan's pharmas have been busy doing deals with U.S. biotechs and are likely to keep up the pace. Here's a look at how they operate and where they're focusing.



footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.